MyFinsight
Home
Blog
About
Back
Income Statement
Alaunos Therapeutics, Inc. (TCRT)
Alaunos Therapeutics, Inc. (TCRT)
source: myfinsight.com
Net loss
-$952,000
(9.42%↑ Y/Y)
Loss from operations
-$952,000
(8.37%↑ Y/Y)
Total operating
expenses
$952,000
(-8.37%↓ Y/Y)
General and
administrative
$564,000
(-33.96%↓ Y/Y)
Research and development
$388,000
(109.73%↑ Y/Y)
Back